We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cell & Gene Therapy Fueled Large Surge in Clinical Holds Last Year
Cell & Gene Therapy Fueled Large Surge in Clinical Holds Last Year
FDA clinical holds saw a sharp increase in 2021, propelled in large part by holds on cell and gene therapy trials, according to an analysis by investment banking firm Jefferies that evaluated holds over the past 12 years.